Submission Details
| 510(k) Number | K912592 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 10, 1991 |
| Decision Date | December 04, 1991 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K912592 is an FDA 510(k) clearance for the CMV-EA MAB TEST, a Antisera, Conjugated Fluorescent, Cytomegalovirus (Class II — Special Controls, product code LIN), submitted by Gull Laboratories, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on December 4, 1991, 177 days after receiving the submission on June 10, 1991. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3175.
| 510(k) Number | K912592 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 10, 1991 |
| Decision Date | December 04, 1991 |
| Days to Decision | 177 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LIN — Antisera, Conjugated Fluorescent, Cytomegalovirus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3175 |